Libros sobre el tema "Theophylline"

A, Maes Robert A., Oellerich Michael y Enders Peter W, eds. Theophylline profile. Weinheim: VCH, 1985.

Maes, R. A. A. Theophylline profile. Weinheim, F.R.G: VCH, 1985.

Friedrich, Kummer, ed. Asthma: Structural body-Theophylline today = strukturelle Grundlagen--Theophyllin heute. New York: Springer-Verlag, 1995.

Hughes, Angela. A theophylline compliance study. Ottawa: Ottawa Civic Hospital, 1990.

Jackson, Stephen Hugh David. Clinical aspects of theophylline pharmacokinetics. Birmingham: University of Birmingham, 1987.

Bowen, James Marshall. Theophylline biotransformation by human lung microsomes. Ottawa: National Library of Canada = Bibliothèque nationale du Canada, 1993.

Purkiss, Ronald. Bioequivalence of sustained release theophylline formulations. Birmingham: Aston University. Department of Pharmaceutical Sciences, 1986.

Minton, Neil Andrew. The clinical pharmacology and toxicology of theophylline. Birmingham: University of Birmingham, 1993.

Shilalukey, Kathleen. Are current pediatric dose recommendations for intravenous theophylline appropriate? Ottawa: National Library of Canada, 1993.

He, Juan. Theophylline 7-[beta]-D ribofuranoside production in mammalian tissues. Ottawa: National Library of Canada, 1994.

M, MacLeod Stuart y Szefler S. J, eds. Childhood asthma and sustained release theophylline: International workshop, Whistler, Canada. Amsterdam: Excerpta Medica, 1986.

Brown, Thomas E. R. A clinical pharmacokinetic monitoring manual for theophylline, vancomycin and aminoglycosides. Toronto: St. Michael's Hospital, 1989.

National Library of Medicine (U.S.), ed. Theophylline pharmacodynamics: January 1983 through October 1985, 352 citations in English. Bethesda, Md: U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, 1985.

Ly, Joseph Pang-Hoi. Development of an oral microspherical formulation for bimodal in vitro release of theophylline. Ottawa: National Library of Canada = Bibliothèque nationale du Canada, 1999.

Arbab, Osman Abubakr. Clinical studies on the use of parenteral aminophylline in patients receiving theophylline preparations. Birmingham: University of Birmingham, 1985.

Dranitsaris, George. In vitro biotransformation of theophylline and resorufin analogues in normal and diseased human liver. Ottawa: National Library of Canada = Bibliothèque nationale du Canada, 1993.

Larsson, Carina Ingvast. Pharmacodynamic effects and pharmacokinetics of theophylline and clenbuterol: In vitro and in vivo studies in the horse and rat. Uppsala: Sveriges Lantbruksuniversitet, 1991.

Post, Marcus Johannes. Specific inhibitors of phosphodiesterase isozymes: New prospects in anti-asthmatic therapy : comparison of milrinone and sulmazole with theophylline and IBMX. [s.l.]: [s.n.], 1989.

Isbruch, Ralf-Dieter. Veränderungen echokardiographischer Funktionsparameter durch Theophyllin-Nitrat bei Patienten stenosierender Coronarsklerose. [s.l.]: [s.n.], 1987.

Schupp, Marco. cAMP-Synthese in peripheren Lymphozyten von Kindern mit Asthma bronchiale: Vergleich unter Behandlung mit Theophyllin und therapiefreien Intervall. [s.l.]: [s.n.], 1991.

J, Vinken P., Bruyn G. W y Wolff F. A. de, eds. Intoxications of the nervous system. Amsterdam: Elsevier Science, 1994.

Sampedrín, Elisa. Theophylline: Poems. House of Anansi Press, 2023.

Kummer, Friedrich. Asthma: Structural Basis-Theophylline Today, Strukturelle Grundlagen, Theophyllin Heute. Springer, 1995.

Gagnon, Antony. "Monitoring" de la theophylline chez les prematures. 1986.

Parker, Philip M. The World Market for Theophylline and Aminophylline (Theophylline-Ethylenediamine), Their Derivatives, and Salts Thereof: A 2007 Global Trade Perspective. ICON Group International, Inc., 2006.

The World Market for Theophylline and Aminophylline (Theophylline-Ethylenediamine), Their Derivatives, and Salts Thereof: A 2004 Global Trade Perspective. Icon Group International, Inc., 2005.

Stevens, Ruth E. Pharmacokinetic modeling of theophylline and dyphylline and pharmacodynamics of ibuprofen input rate on antipyresis. 1992.

He, Juan. Theophylline 7-B-D ribofuranoside production in mammalian tissues. 1995.

Rietbrock, Norbert. Theophylline and other Methylxanthines / Theophyllin und andere Methylxanthine: Proceedings of the 4th International Symposium, Frankfurt/M., 29th and ... clinical pharmacology ). Vieweg+Teubner Verlag, 2012.

Knoppert, David Cornelius. The disposition of theophylline and its metabolites in cystic fibrosis. 1986.

Sustained release theophylline and nocturnal asthma: International workshop, Bürgenstock, Switzerland. Amsterdam: Excerpta Medica, 1985.

Palmer, Derek Adeyemi. Sensing of theophylline by enzyme immunoassay coupled with electrochemical detection. 1991.

Szot, Patricia. Adenosine receptor modulation of seizure susceptibility in rats. 1987.

Asthma. Island Press, 1995.

Asthma. Island Press, 1993.

Ho, George. Evaluation of the effect of norfloxacin on the pharmacokinetics of theophylline. 1987.

Janssens, S. Effects of Theophylline on Respiratory Skeletal Muscle -an Experimental Study in Dogs. Leuven University Press, 1993.

Lindsay, Christine A. Conversion from intravenous theophylline to oral somophyllin-12: standardization in children with asthma. 1988.

Ly, Joseph Pang-Hoi. Development of an oral microspherical formulation for bimodal "in vitro" release of theophylline. 1997.

Ly, Joseph Pang-Hoi. Development of an oral microspherical formulation for bimodal "in vitro" release of theophylline. 1997.

Dranitsaris, George. In vitro biotransformation of the theophylline and resorufin analogues in normal and diseased human liver. 1992.

Isles, A. F. Sustained Release Theophylline and Nocturnal Asthma: International Workshop, Burgenstock, Switzerland (Current Clinical Practice Series, No 18). Elsevier Science & Technology, 1985.

Awosika, Ajoritsedere. Biopharmacy of sustained-release theophylline: Design criteria for sustained-release (SR) medicines and analysis of performance of U.K.-licenced theophylline products : formulation of a new SR granular product with improved in vitro and in vivo characteristics. Bradford, 1985.

Theophylline and Other Methylxanthines / Theophyllin und Andere Methylxanthine: Proceedings of the 4th International Symposium, Frankfurt/M. , 29th and 30th May, 1981 / Vorträge des 4. Internationalen Symposiums, Frankfurt/M. , 29. und 30. Mai 1981. Vieweg Verlag, Friedr, & Sohn Verlagsgesellschaft mbH, 2013.

Chrystyn, Henry. Pharmacodynamics of theophylline in irreversible chronic airflow obstruction: Dose-response relationships --- : effects on trapped gas volumes and excercise tolerance;accuracy of drug levels ---. Bradford, 1987.

Jaeger, Albert. Role of toxicology assessment in poisoning. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199600830.003.0315.

Deiriggi, Pamela Marie. THE EFFECTS OF WATERBED FLOTATION ON INDICATORS OF ENERGY EXPENDITURE--ACTIVITY LEVEL, HEART RATE, AND BEHAVIORAL STATE--IN PREMATURE INFANTS (THEOPHYLLINE, INFANT STIMULATION, VESTIBULAR). 1986.

Köller, Gerhard. Herstellung und Eigenschaften bioabbaubarer Theophyllin-Polymilchsäure-Tabletten. 1991.

MacNnoli, Marcellinus Chukwunwike. Klinischer Wirkungsvergleich zwischen einer Ketotifen-Theophyllin-Kombination und der Einzelkomponente Theophyllin bei Erwachsenen mit exogen allergischem Asthma bronchiale. 1990.

Terwey-Weber, Helga. Theophyllin-induzierte Veränderungen Doppler-sonographischer Strömungsparameter bei Früh- und Neugeborenen. 1990.